NASDAQ:CSBR

Champions Oncology Stock Forecast

etoro logo Buy CSBR
*Your capital is at risk
$6.75
-0.0500 (-0.735%)
At Close: Nov 17, 2025
AI Analysis AI Analysis of CSBR
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

Champions Oncology stock price ended at $6.75 on Monday, after losing 0.735%
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Oct 22, 2025 Gain 0.75%

The Champions Oncology stock price fell by -0.735% on the last day (Monday, 17th Nov 2025) from $6.80 to $6.75. During the last trading day the stock fluctuated 3.44% from a day low at $6.68 to a day high of $6.91. The price has fallen in 6 of the last 10 days and is down by -0.74% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -14 thousand shares and in total, 10 thousand shares were bought and sold for approximately $64.79 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.18% during the next 3 months and, with a 90% probability hold a price between $5.95 and $7.85 at the end of this 3-month period.

CSBR Signals & Forecast

The Champions Oncology stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $6.83. On a fall, the stock will find some support from the long-term average at approximately $6.68. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Friday, September 26, 2025, and so far it has risen 7.14%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Champions Oncology stock

Champions Oncology finds support from accumulated volume at $6.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.230 between high and low, or 3.44%. For the last week the stock has had daily average volatility of 2.91%

Our recommended stop-loss: $6.48 (-4.04%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 36 days ago.)

Trading Expectations (CSBR) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Champions Oncology to open at $6.78, and during the day (based on 14 day Average True Range), to move between $6.64 and $6.86, which gives a possible trading interval of +/-$0.222 (+/-3.35%) up or down from last closing price. If Champions Oncology takes out the full calculated possible swing range there will be an estimated 3.35% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $6.70 (0.74%) than the resistance at $6.97 (3.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Champions Oncology stock A Buy?

Champions Oncology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.721 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $6.78 ( 0.444%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

CSBR Performance

Trading levels for CSBR

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 7.01 3.85%
R2 6.92 2.55%
R1 6.87 1.75%
Price 6.75
S1 6.69 -0.86%
S2 6.64 -1.66%
S3 6.55 -2.96%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.30 22.96%
R2 7.62 12.89%
R1 6.97 3.26%
Price 6.75
S1 6.70 -0.741%
S2 6.46 -4.30%
S3 6.35 -5.93%

FAQ

What is the symbol for Champions Oncology Stock and on which exchange is it traded?
The symbol for Champions Oncology is CSBR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Champions Oncology Stock?
Champions Oncology holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Champions Oncology Stock?
Champions Oncology Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Champions Oncology Stock.

What's the current price of Champions Oncology Stock?
As of the end of day on the Nov 17, 2025, the price of an Champions Oncology (CSBR) share was $6.75.

What is the 52-week high and low for Champions Oncology Stock?
The 52-week high for Champions Oncology Stock is $11.99 and the 52-week low is $4.07.

What is the market capitalization of Champions Oncology Stock?
As of the Nov 17, 2025, the market capitalization of Champions Oncology is 93.049M.

When is the next earnings date for Champions Oncology?
The upcoming earnings date for Champions Oncology is Dec 10, 2025.
Click to get the best stock tips daily for free!
ABOUT CHAMPIONS ONCOLOGY
Champions Oncology
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE